Global Cancer Antigen Market Growth (Status and Outlook) 2025-2031

According to this study, the global Cancer Antigen market size will reach US$ million by 2031.

Cancer antigens are certain types of proteins secreted into the bloodstream and can be measured in both cancers and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancer cells and other cells of the body which provides information about cancer.

United States market for Cancer Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cancer Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cancer Antigen is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cancer Antigen players cover Thermo Fisher Scientific, Roche, Tellgen, Labor Diagnostika Nord, Henso Medical (Hangzhou), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Cancer Antigen Industry Forecast” looks at past sales and reviews total world Cancer Antigen sales in 2024, providing a comprehensive analysis by region and market sector of projected Cancer Antigen sales for 2025 through 2031. With Cancer Antigen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Antigen industry.

This Insight Report provides a comprehensive analysis of the global Cancer Antigen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cancer Antigen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Antigen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Antigen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Antigen.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Antigen market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cancer Antigen 125
Cancer Antigen 15-3
Cancer Antigen 27-29
Cancer Antigen 19-9
Others

Segmentation by Application:
Hospitals
Diagnostic Centres
Ambulatory Surgical Centres
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Roche
Tellgen
Labor Diagnostika Nord
Henso Medical (Hangzhou)
Multisciences (Lianke) Biotech
Hangzhou AllTest Biotech
SHINJIN Medics
Xiamen Baysen Medica Tech

Please note: The report will take approximately 2 business days to prepare and deliver. Show more